MENU
+Compare
SCLX
Stock ticker: NASDAQ
AS OF
Apr 8, 04:59 PM (EDT)
Price
$0.24
Change
-$0.01 (-4.00%)
Capitalization
165.55M

SCLX Scilex Holding Company Forecast, Technical & Fundamental Analysis

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain... Show more

SCLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SCLX with price predictions
Apr 07, 2025

SCLX's RSI Indicator ascends from oversold territory

The RSI Oscillator for SCLX moved out of oversold territory on April 02, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 24 similar instances when the indicator left oversold territory. In of the 24 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 40 cases where SCLX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SCLX just turned positive on April 02, 2025. Looking at past instances where SCLX's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SCLX advanced for three days, in of 155 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SCLX as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCLX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SCLX entered a downward trend on March 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: SCLX's P/B Ratio (18.215) is slightly higher than the industry average of (5.632). P/E Ratio (0.000) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.004). Dividend Yield (0.000) settles around the average of (0.161) among similar stocks. P/S Ratio (4.348) is also within normal values, averaging (3.643).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SCLX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SCLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.

View a ticker or compare two or three
SCLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
960 San Antonio Road
Phone
+1 650 516-4310
Employees
105
Web
https://www.scilexholding.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WSTAX41.510.64
+1.57%
Macquarie Science and Technology A
BMPSX76.43N/A
N/A
ProFunds Materials UltraSector Svc
SGQIX37.47N/A
N/A
DWS International Growth Inst
MFWLX15.88N/A
N/A
MFS Global Total Return R6
ABYEX8.36N/A
N/A
AB Emerging Markets Multi-Asset Advisor

SCLX and Stocks

Correlation & Price change

A.I.dvisor tells us that SCLX and BIIB have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCLX and BIIB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCLX
1D Price
Change %
SCLX100%
-12.68%
BIIB - SCLX
20%
Poorly correlated
-3.08%
AMRN - SCLX
20%
Poorly correlated
+1.34%
JNJ - SCLX
10%
Poorly correlated
-1.71%
ABBV - SCLX
9%
Poorly correlated
-0.22%
RHHVF - SCLX
8%
Poorly correlated
-4.98%
More